✦ LIBER ✦

Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis

✍ Scribed by Paul J. Hoffman; Dawn B. Milliken; Laurie C. Gregg; Ryan R. Davis; Jeffrey P. Gregg

Book ID: 118443535
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 205 KB
Volume: 82
Category: Article
ISSN: 1556-5653
DOI: 10.1016/j.fertnstert.2004.01.047

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular and Cytogenetic Characterizati

Molecular and Cytogenetic Characterization of Plexiform Leiomyomata Provide Further Evidence for Genetic Heterogeneity Underlying Uterine Fibroids

✍ Jennelle C. Hodge; Bradley J. Quade; Mark A. Rubin; Elizabeth A. Stewart; Paola 📂 Article 📅 2008 🏛 American Society for Investigative Pathology 🌐 English ⚖ 681 KB

Genetic and molecular mechanisms of vira

Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment

✍ Fields, Bernard N.; Greene, Mark I. 📂 Article 📅 1982 🏛 Nature Publishing Group 🌐 English ⚖ 647 KB

Characterization of therapy and costs fo

Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid

✍ Gary Oderda; Carl Asche; Kirtly Parker Jones; Ray M. Merrill; James Spalding 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 389 KB

W15.410 Molecular mechanisms underlying

W15.410 Molecular mechanisms underlying the potential antiatherogenic effect of pistacia lentiscus resin: Implication of GSH and CD36 molecules

✍ Dedoussis, G.; Kaliora, A.; Psarras, S.; Papadopoulos, N.; Andrikopoulos, N. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Molecular mechanisms underlying the role

Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice

✍ Elisa Giovannetti; Ayse Erozenci; Jorn Smit; Romano Danesi; Godefridus J. Peters 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 586 KB

Review of the recently defined molecular

Review of the recently defined molecular mechanisms underlying thanatophoric dysplasia and their potential therapeutic implications for achondroplasia

✍ María Luisa Martínez-Frías; Cristina A. de Frutos; Eva Bermejo; ECEMC Working Gr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 2 views

## Abstract Achondroplasia (ACH), thanatophoric dysplasia (TD) types I and II, hypochondroplasia (HCH), and severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) are all due to activating mutations in the fibroblast growth factor receptor 3 (__FGFR3__) gene. We review the